Difference in Cerebral Microembolization With Multielectrode Pentaspline or Variable‐Loop Circular PFA Systems
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70218 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Mattia Pagnoni und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Intracranial Embolism, Catheter Ablation, Pulmonary Veins, Atrial Fibrillation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulsed field ablation (PFA) is a largely nonthermal modality with myocardial selectivity and collateral damage sparing. Cerebrovascular safety remains an important consideration as catheter design and pulse parameters may influence embolic risk. Microembolic signals (MES), detected by transcranial Doppler (TCD) ultrasonography, may offer a sensitive real‐time surrogate for procedural‐related embolic activity.
Methods
We prospectively compared MES burden between two PFA systems: a multielectrode Pentaspline catheter (Farawave, Boston Scientific) and a more recently introduced variable‐loop circular catheter (VLCC) (Varipulse, Biosense Webster). Consecutive patients undergoing first‐time pulmonary vein isolation for AF were included. ACT targets were > 300 s (Pentaspline) and > 350 s (VLCC), and ablation was delivered according to manufacturer‐recommended workflows.
Results
Among 23 patients (16 Pentaspline, 7 VLCC), ACT was maintained above respective targets in all, and left atrial dwell time was comparable. The total number of PFA deliveries was significantly higher in the Pentaspline group compared to the VLCC group (51 [46–66] vs. 22 [22–25], p < 0.001). The MES burden was significantly higher with VLCC during ablation time (919 [154–2302] vs. 102 [52–248], p = 0.005). This difference was even higher when normalized by the delivered‐to‐recommended PFA deliveries ratio ( p = 0.005). In addition, MES burden with VLCC displayed markedly greater inter‐patient variability, whereas Pentaspline results were more reproducible (IQR 2148 vs. 196, p < 0.001).
Conclusions
VLCC PFA was associated with higher and more variable cerebral microembolization compared with the Pentaspline system. These findings underscore the impact of catheter design and energy delivery on embolic load and highlight the need for dedicated cerebrovascular safety evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Division of Neurology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Zitieren
APA
Pagnoni, M., Caranzano, L., Teres, C., Ascione, C., Le Bloa, M., Antiochos, P., Luca, A., Solana-Muñoz, J., Ortolani, D., Andrade Azevedo, D., Pruvot, E., Hirt, L., & Pascale, P. (2026). Difference in Cerebral Microembolization With Multielectrode Pentaspline or Variable‐Loop Circular PFA Systems. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70218
Vancouver
Pagnoni M, Caranzano L, Teres C, Ascione C, Le Bloa M, Antiochos P, et al. Difference in Cerebral Microembolization With Multielectrode Pentaspline or Variable‐Loop Circular PFA Systems. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70218
BibTeX
@article{Pagnoni2026,
author = {Pagnoni, Mattia and Caranzano, Leonardo and Teres, Cheryl and Ascione, Ciro and Le Bloa, Mathieu and Antiochos, Panagiotis and Luca, Adrian and Solana-Muñoz, Jorge and Ortolani, Diana and Andrade Azevedo, Daniel and Pruvot, Etienne and Hirt, Lorenz and Pascale, Patrizio},
title = {Difference in Cerebral Microembolization With Multielectrode Pentaspline or Variable‐Loop Circular PFA Systems},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70218}
}
EUVIMED